Navin Fluorine International has achieved a significant operational milestone by commencing commercial production at Phase 1 of its CGMP-4 plant located in Dewas. This development marks an important step in the company's manufacturing expansion strategy and demonstrates its commitment to enhancing production capabilities in the specialty chemicals sector.

Facility Launch Details

The company has successfully initiated commercial operations at the first phase of its CGMP-4 manufacturing facility in Dewas. This milestone represents the culmination of the company's investment in expanding its manufacturing infrastructure and production capacity.

Strategic Significance

The commencement of commercial production at the CGMP-4 plant represents a key development in Navin Fluorine International's operational expansion. The facility is expected to contribute to the company's manufacturing capabilities and strengthen its position in the specialty chemicals market. This operational milestone aligns with the company's growth strategy and commitment to expanding its production infrastructure.

Manufacturing Enhancement

With the start of commercial production at Phase 1 of the CGMP-4 plant, Navin Fluorine International has enhanced its manufacturing footprint. The Dewas facility adds to the company's existing production capabilities and is positioned to support the company's operational objectives in the specialty chemicals segment.

Navin Fluorine International Limited has completed the allotment of 2,850 equity shares to eligible employees under its Employees Stock Option Scheme 2017 on December 18, 2025. The allotment was executed following the exercise of stock options by employees and was approved by the company's Nomination and Remuneration Committee.

Share Allotment Details

The allotment specifics are presented in the following table:

Updated Share Capital Structure

Following this allotment, Navin Fluorine International's share capital structure has been updated as follows:

Share Rights and Ranking

The newly allotted equity shares will rank pari-passu in all respects with the existing equity shares of the company. This means the new shares carry identical rights and privileges as the current shareholding, including voting rights, dividend entitlements, and other corporate benefits.

Corporate Communication

The company has formally notified both BSE Limited and National Stock Exchange of India Limited about this allotment. Navin Fluorine International trades on BSE under scrip code 532504 and on NSE under the symbol NAVINFLUOR. The communication was signed by Niraj B. Mankad, President Legal and Company Secretary, ensuring compliance with regulatory disclosure requirements.